144 related articles for article (PubMed ID: 31391566)
1. Wind-down of stem-cell institute leaves a void.
Loring JF
Nature; 2019 Aug; 572(7768):155. PubMed ID: 31391566
[No Abstract] [Full Text] [Related]
2. Stem cells: Hope on the line.
Hayden EC
Nature; 2014 Jul; 511(7507):19-21. PubMed ID: 24990726
[No Abstract] [Full Text] [Related]
3. Stem cells: The impatient advocate.
Dolgin E
Nature; 2010 Dec; 468(7324):620-3. PubMed ID: 21124428
[No Abstract] [Full Text] [Related]
4. California Institute for Regenerative Medicine: accelerating stem cell therapies in California and beyond.
Trounson A
Stem Cells Transl Med; 2012 Jan; 1(1):6-8. PubMed ID: 23197633
[No Abstract] [Full Text] [Related]
5. California's vote to revive controversial stem-cell institute sparks debate.
Subbaraman N
Nature; 2020 Nov; 587(7835):535. PubMed ID: 33199902
[No Abstract] [Full Text] [Related]
6. Alan Trounson, CIRM’s departed president: surprises, optimism, malaise.
Parson AB
Cell Stem Cell; 2014 Oct; 15(4):403-5. PubMed ID: 25405247
[No Abstract] [Full Text] [Related]
7. UK launches a new centre of excellence for stem cell research.
Qadir Z
Lancet; 2012 Aug; 380(9841):549. PubMed ID: 22891371
[No Abstract] [Full Text] [Related]
8. Regenerative medicine. CIRM: the good, the bad, and the ugly.
Miller G
Science; 2010 Dec; 330(6012):1742-3. PubMed ID: 21205649
[No Abstract] [Full Text] [Related]
9. State stem cell agency floats idea of $70 million 'Alpha' clinics.
Dolgin E
Nat Med; 2013 Jul; 19(7):798. PubMed ID: 23836206
[No Abstract] [Full Text] [Related]
10. California institute for regenerative medicine: accelerating stem cell therapies in California and beyond.
Trounson A
Stem Cells; 2012 Mar; 30(3):357-9. PubMed ID: 22334457
[No Abstract] [Full Text] [Related]
11. REGENERATIVE MEDICINE. California stem cell agency plots a race to the clinic.
Servick K
Science; 2016 Jan; 351(6268):15. PubMed ID: 26721984
[No Abstract] [Full Text] [Related]
12. Open for business.
Nature; 2007 Mar; 446(7133):232. PubMed ID: 17361139
[No Abstract] [Full Text] [Related]
13. Stem-cell agency faces budget dilemma.
Hayden EC
Nature; 2012 Jan; 482(7383):15. PubMed ID: 22297945
[No Abstract] [Full Text] [Related]
14. Local and global returns from research in stem cells: the case of the California Institute for Regenerative Medicine.
Alberro J
Regen Med; 2012 Jul; 7(4):605-13. PubMed ID: 22817632
[TBL] [Abstract][Full Text] [Related]
15. Stem cells: the 3-billion-dollar question.
Hayden EC
Nature; 2008 May; 453(7191):18-21. PubMed ID: 18461716
[No Abstract] [Full Text] [Related]
16. Stem cells on the ballot.
Goldstein LSB; Klein RN
Science; 2021 Jan; 371(6526):215. PubMed ID: 33446531
[No Abstract] [Full Text] [Related]
17. Global update: England and Wales.
Ilic D
Regen Med; 2011 Nov; 6(6 Suppl):144-7. PubMed ID: 21999278
[TBL] [Abstract][Full Text] [Related]
18. Global update: Scotland.
Courtney A
Regen Med; 2011 Nov; 6(6 Suppl):150-2. PubMed ID: 21999279
[TBL] [Abstract][Full Text] [Related]
19. California institute to help stem-cell biotechs.
Hayden EC
Nature; 2008 Sep; 455(7212):436-7. PubMed ID: 18818612
[No Abstract] [Full Text] [Related]
20. Stem-cell researcher's move attracts funding.
Check E
Nature; 2007 Jul; 448(7152):398. PubMed ID: 17653156
[No Abstract] [Full Text] [Related]
[Next] [New Search]
